Los Angeles-based Response Genetics, a firm developing molecular diagnostic tests for cancer, announced this morning that its Chief Financial Officer, Thomas Stankovich, has resigned. The firm said that Stankovich resigned to "pursue other interests." The firm said that Eric Alcorn, the firm's VP of Finance and Administration, will assume CFO responsibilities while the firm conducts a search for a replacement.